AVTR
Price
$9.43
Change
+$0.08 (+0.86%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
6.44B
29 days until earnings call
Intraday BUY SELL Signals
XRAY
Price
$10.20
Change
+$0.05 (+0.49%)
Updated
Jun 23 closing price
Capitalization
2.04B
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVTR vs XRAY

AVTR vs XRAY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AVTR vs. XRAY commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTR is a Hold and XRAY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (AVTR: $9.43 vs. XRAY: $10.20)
Brand notoriety: AVTR and XRAY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AVTR: 115% vs. XRAY: 84%
Market capitalization -- AVTR: $6.44B vs. XRAY: $2.04B
AVTR [@Pharmaceuticals: Other] is valued at $6.44B. XRAY’s [@Pharmaceuticals: Other] market capitalization is $2.04B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $142.79B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTR’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • AVTR’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, both AVTR and XRAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTR’s TA Score shows that 4 TA indicator(s) are bullish while XRAY’s TA Score has 5 bullish TA indicator(s).

  • AVTR’s TA Score: 4 bullish, 6 bearish.
  • XRAY’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, XRAY is a better buy in the short-term than AVTR.

Price Growth

AVTR (@Pharmaceuticals: Other) experienced а -1.46% price change this week, while XRAY (@Pharmaceuticals: Other) price change was -2.39% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.32%. For the same industry, the average monthly price growth was -1.03%, and the average quarterly price growth was -14.58%.

Reported Earning Dates

AVTR is expected to report earnings on Jul 23, 2026.

XRAY is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.32% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTR($6.44B) has a higher market cap than XRAY($2.04B). XRAY YTD gains are higher at: -10.761 vs. AVTR (-17.714). AVTR has higher annual earnings (EBITDA): 114M vs. XRAY (-127M). AVTR has more cash in the bank: 279M vs. XRAY (190M). XRAY has less debt than AVTR: XRAY (2.33B) vs AVTR (3.82B). AVTR has higher revenues than XRAY: AVTR (6.55B) vs XRAY (3.68B).
AVTRXRAYAVTR / XRAY
Capitalization6.44B2.04B315%
EBITDA114M-127M-90%
Gain YTD-17.714-10.761165%
P/E Ratio14.93N/A-
Revenue6.55B3.68B178%
Total Cash279M190M147%
Total Debt3.82B2.33B164%
FUNDAMENTALS RATINGS
AVTR vs XRAY: Fundamental Ratings
AVTR
XRAY
OUTLOOK RATING
1..100
8633
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
2
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9598
PRICE GROWTH RATING
1..100
5062
P/E GROWTH RATING
1..100
9883
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (2) in the Medical Specialties industry is somewhat better than the same rating for AVTR (62) in the null industry. This means that XRAY’s stock grew somewhat faster than AVTR’s over the last 12 months.

XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AVTR (100) in the null industry. This means that XRAY’s stock grew similarly to AVTR’s over the last 12 months.

AVTR's SMR Rating (95) in the null industry is in the same range as XRAY (98) in the Medical Specialties industry. This means that AVTR’s stock grew similarly to XRAY’s over the last 12 months.

AVTR's Price Growth Rating (50) in the null industry is in the same range as XRAY (62) in the Medical Specialties industry. This means that AVTR’s stock grew similarly to XRAY’s over the last 12 months.

XRAY's P/E Growth Rating (83) in the Medical Specialties industry is in the same range as AVTR (98) in the null industry. This means that XRAY’s stock grew similarly to AVTR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTRXRAY
RSI
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
62%
Momentum
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
46%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 15 days ago
62%
Bullish Trend 8 days ago
55%
Declines
ODDS (%)
Bearish Trend 7 days ago
74%
Bearish Trend 21 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
AVTR
Daily Signal:
Gain/Loss:
XRAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GSKH73.662.05
+2.87%
GSK PLC ADRHEDGED
FMF50.33-0.59
-1.16%
First Trust Managed Future Strategy ETF
SPXV81.15-1.25
-1.52%
ProShares S&P 500® ex-Health Care
RGLO32.01-0.56
-1.72%
Russell Inv Global Equity ETF
TNA71.42-2.20
-2.99%
Direxion Daily Small Cap Bull 3X ETF

AVTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTR has been loosely correlated with RGEN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTR jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTR
1D Price
Change %
AVTR100%
+0.86%
RGEN - AVTR
51%
Loosely correlated
-0.14%
BCPC - AVTR
40%
Loosely correlated
+0.22%
XRAY - AVTR
40%
Loosely correlated
+0.49%
AVNT - AVTR
38%
Loosely correlated
-4.05%
BLFS - AVTR
36%
Loosely correlated
-0.48%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
+0.49%
NVST - XRAY
62%
Loosely correlated
-0.98%
ALGN - XRAY
51%
Loosely correlated
-3.03%
QDEL - XRAY
50%
Loosely correlated
-3.56%
KIDS - XRAY
48%
Loosely correlated
+1.38%
BAX - XRAY
47%
Loosely correlated
+2.24%
More